UK regulator maps out pathway for stem cell work
This article was originally published in Scrip
Executive Summary
TheMHRA, the UK medicines regulator, has created an interim regulatory route map for stem cell research and manufacture for those whose work with stem cells might ultimately lead to clinical application.